EnteroMedics (NSDQ:ETRM) said today its board authorized a 1-for-15 reverse stock split, effective on January 7 next year. As a result of the split, every 15 shares of stock in the St. Paul, Minn.-based company will be consolidated into a single share. Shares in EnteroMedics dipped today in mid-day trading in response, down 4.7% at 12.7¢ […]
EnteroMedics Inc.
EnteroMedics names ex-Lanx chief Gladney as CEO | Personnel Moves
EnteroMedics (NSDQ:ETRM) said it named Dan Gladney, the former chief executive who led Lanx to an acquisition by Biomet, to be its new CEO effective Nov. 16. St. Paul, Minn.-based EnteroMedics said chairman, president & CEO Mark Knudson will become executive chairman when Gladney takes over the corner office until Jan. 1, 2016, when he will […]
Reva Medical snags ex-MDT’er Groves for CEO | Personnel Moves
Reva Medical (ASX:RVA) said last week it picked up ex-Medtronic (NYSE:MDT) divisional veep Regina Groves as its new CEO. Groves was vice president and GM of the atrial fibrillation solutions, cardiac rhythm and heart failure division at Medtronic. During her time there, she helped the company strategize a re-entry into the catheter-based atrial fibrillation ablation market, the […]
BrainScope wrangles up new C-suite | Personnel Moves
Brainscope today announced a number of new assignments to its executive roster, assigning 4 new picks to its c-suite. The Bethesda, Ma.-based neurotech company picked up Dr. Leslie Prichep as chief scientific officer, Kerstin Schultz as president and COO, Angad Singh as chief technology officer, and promoted Laurie Silver to CFO. “These additions to our leadership team will help […]
EnteroMedics touts 18-month sham-controlled data on vBloc device
EnteroMedics (NSDQ:ETRM) said today that 18-month results of a sham-controlled study of its vBloc therapy, used by its flagship Maestro device, was published in the Journal of Obesity The 239-patient pivotal Recharge trial examined weight-loss differences between patients who were implanted with the Maestro device, which provides vBloc therapy, and patients who were implanted with […]
EnteroMedics closes $16m follow-on
EnteroMedics (NSDQ:ETRM) yesterday said it netted $14.7 million from a follow-on offering it initially hoped would gross $35 million. St. Paul, Minn.-based EnteroMedics initially planned to float 40.2 million shares at 87¢ apiece,for gross proceeds of $35 million. That offering was to have consisted of 1 ETRM share, plus Series A and Series B warrants. But the company was […]
UPDATE: EnteroMedics prices retooled follow-on at $16m
UPDATED July 7, 2015, with pricing information. EnteroMedics (NSDQ:ETRM) today priced a retooled follow-on offering, which it hoped would raise $35 million, saying it now hopes to bring in $16 million. St. Paul, Minn.-based EnteroMedics initially planned to float 40.2 million shares at 87¢ apiece, for gross proceeds of $35 million. The offering was to have consisted of 1 […]
EnteroMedics prices follow-on offering at $35m
EnteroMedics (NSDQ:ETRM) said yesterday it has priced a follow-on offering of 40.2 million shares of stock at 87¢ per share, slated to raise gross proceeds of $35 million. The St. Paul, Minn.-based company said it expects to net $32.9 million from the offering, which it will use to continue to support its Maestro obesity device. […]
EnteroMedics registers for $15m follow-on
EnteroMedics (NSDQ:ETRM) today registered for a follow-on offering that could bring in as much as $15 million for its Maestro obesity device. St. Paul, Minn.-based EnteroMedics won FDA approval for the Maestro device in January 2015, following a mixed vote last year after the device failed to meet its efficacy endpoint in a clinical trial. It’s designed to […]
New JenaValve CEO is Boston Scientific vet Carr-Brendel | Personnel Moves
JenaValve said this week that it tapped Victoria Carr-Brendel, former general manager of Boston Scientific‘s (NYSE:BSX) Bayer Interventional business, as its new chief executive officer. Carr-Brendel will replace Jan Keltjens, who served as interim CEO of the transcatheter aortic valve repair-focused company since January 2015. Keltjens will remain with the company as chairman of the board, JenaValve said. […]